What is Psychedelic Science Org UK?
Psychedelic science org uk is a crowd-funding campaign that aims to raise funds for scientific research with psychedelic drugs, with a special focus on a clinical trial assessing the safety and efficacy of psilocybin as a treatment for depression.
Psychedelic Science org uk was founded by Dr Robin Carhart-Harris in August 2014. Robin is a psychopharmacologist working at Imperial College London in the Centre for Neuropsychopharmacology, on scientific research with psychedelic drugs. Professor David Nutt is the Edmond J Safra Chair in Neuropsychopharmacology at Imperial College London. David and Robin have been working with Amanda Feilding, Director of the Beckley Foundation, carrying out pioneering brain-imaging research with psychedelic drugs, such as psilocybin (magic mushrooms), MDMA and LSD, as part of the Beckley Foundation/Imperial College Psychopharmacological Research Programme.
Why does this matter?
Depression is a serious global problem. It’s the leading cause of disability worldwide, is linked to over half of all suicides, and affects some 350 million people. Worse still, the prevalence of depression is increasing; the World Health Organisation estimates that depression will become the leading overall contributor to the global burden of disease by 2030.
Mental health research is seriously under-funded, especially when compared with other major illnesses such as cancer and heart disease and so the funding that is available for depression research isn’t in any way proportional to the size of the problem.
Depression is also extremely difficult to treat. Around half of patients with depression do not respond to treatment with antidepressant medication and these medications, while effective in some patients, are associated with side-effects and need to be taken daily. Worse still, up to 20% of people do not respond to any treatment at all and this leaves them isolated and with little hope. Options for severe depression are limited and include such things as electroconvulsive therapy (ECT) and more aggressive medication strategies. Our psilocybin research is focused on helping this group of ‘treatment resistant’ patients by offering an alternative option for their depression.
Why might psilocybin be helpful?
Psilocybin occurring naturally in certain mushroom species has been used for millennia by some cultures for healing purposes but Western medicine only became privy to the therapeutic potential of psilocybin in the late 1950s when the Swiss chemist Albert Hofmann identified it as the major psychoactive ingredient of ‘magic mushrooms’. Thereafter, for a period of about 10 years, psilocybin was used in psychotherapy for the treatment of various psychiatric disorders including depression. The results of this work were extremely promising, with some psychiatrists heralding psychedelics as breakthrough medicines with immense scientific and therapeutic potential. Indeed, one even declared that: “Psychedelics could be for psychiatry what the microscope is for biology or the telescope for astronomy.” (Stan Grof, 1975)
Regrettably, a conservative backlash on psychedelics occurred in the late 1960s, fuelled by escalating recreational use and a surrounding hysteria stoked by sensationalistic media reporting. These events led to the cessation of legitimate scientific and clinical research with psychedelics and this effective prohibition on psychedelic science lasted for several decades.
Thankfully, clinical research with psychedelics is currently experiencing somewhat of a renaissance. Recent pilot studies in the US have suggested that psilocybin-assisted psychotherapy may be effective for treating obsessive compulsive, anxiety related to dying and depression. Other research teams have been looking at the potential of psilocybin to treat alcohol and tobacco dependence, with very promising preliminary results and one particularly impressive study found that just a single experience with psilocybin improved well-being and life satisfaction for well over one year in two thirds of their study participants.
At Imperial College, our own research has focused on the brain effects of psychedelics, using cutting-edge brain imaging techniques such as fMRI and MEG. In 2012, we published a paper reporting that psilocybin changes brain activity in a manner that is consistent with a large range of effective treatments for depression. More specifically, we found that circuits that are over-active and reinforced in depression become loosened and normalised under psilocybin. Briefly, psilocybin works on the serotonin system. Serotonin is a chemical messenger in the brain that is linked to the regulation of mood. Broadly speaking, increased serotonin signalling is associated with elevated mood, and psilocybin (which, molecularly, looks a lot like serotonin) works to mimic some of serotonin’s actions. That psilocybin does this, may explain why it may be useful in the treatment of depression.
Our videos describing different aspects of what we do.
Mendel Kaelen: Psychological & Neurophysiological Effects of Music in Combination with Psychedelics
Comeback of psychedelics in science and medicine: Robin Carhart Harris
Can Magic Mushrooms treat depression?- Robin Carhart-Harris at New Scientist Live 2017
EXCLUSIVE: Could magic mushrooms treat depression? BBC Newsnight
Robin Carhart-Harris - Psychedelic drugs in science and medicine
- on The administration of psilocybin to healthy hallucinogen experienced volunteers Hello, I am 63 years old and am struggling with severe depression. I used many psycedelics during my teens and well into my 20s. Actually used LSD as a method of marriage communication. It was very helpful. Now 35-40 years later and nothing helps thi…
- on Help us treat depression! Hi. I would very much like to participate in a trial. I'm 49 and have suffered most of my life with anxiety and depression. I'm currently on dual reuptake inhibitors but they have limited effect for me. I've tried many, many things over the years to…
- on The administration of psilocybin to healthy hallucinogen experienced volunteers Hello everyone I'm on antidepressant from couple of years and I try many different types. Right now I have worst time ever. I try mushrooms which one found my self on last season 2016. I have found but that was very difficult for me. I go nearly ever…
- on Help us treat depression! I would be very interested to hear about your research on your use of psychedelics , I would be very interested if you are looking for new volunteers for further trials , I am 50 years old and I have suffered with depression for 25 years and have fou…
- on The administration of psilocybin to healthy hallucinogen experienced volunteers Hi, I have read your articles and I am currently on anti depressants. I have tried different kinds as I have mild PTSD from military service and suffer from depression constantly. I would very much like to assist and be a volunteer for future trials.
- on The administration of psilocybin to healthy hallucinogen experienced volunteers Hello, I’m am 43 year old male living in oxford and suffered from depression and anxiety for 20 some years and I am a chronic suffer. I am very interested in participating on this type of drug trial. In my 20’s I have picked my own mushrooms once or…
- on Are you having a psychedelic experience in the near future? Hi All, I suffer from depression and anxiety and have done so for many years. After being placed on anti-depressants (again), I had a very bad response and the side effects of increased suicidal thoughts became unbearable. It was an everyday battle o…
- on Help us treat depression! Hello, I am wondering if you have completed your research into the use of psychedelics to aid with depression. I suffer with it myself and want to know if you are still looking for volunteers? I am currently 20 years old, turning 21 in September. I a…